Why the study?
Does intrapericardial tranexamic acid improve the management of pericardial bleeding complications in patients undergoing percutaneous endo-epicardial catheter ablation for atrial fibrillation?
Does intrapericardial tranexamic acid improve the management of pericardial bleeding complications in patients undergoing percutaneous endo-epicardial catheter ablation for atrial fibrillation?
The text proposes the potential use of intrapericardial tranexamic acid for managing pericardial bleeding complications during endo-epicardial catheter ablation for atrial fibrillation.
Epicardial connections have been identified as an important cause for failed endocardial atrial fibrillation (AF) ablations. Percutaneous and/or surgical techniques for stand-alone epicardial or combined endo-epicardial ablations are increasingly used to overcome this limitation and achieve durable transmural lesions for sustained isolation of pulmonary veins and complete block across linear atrial lines, which has been shown to translate in a reduced AF / atrial tachycardia recurrence rate.1,2 This trend has been facilitated and promoted by the development of safer percutaneous subxiphoid epicardial access techniques, such as the carbon dioxide insufflation over intentional coronary vein exit, substantially reducing the risk of puncture-related complications3 and allowing to perform them on uninterrupted anticoagulation.
No takes yet. Share an insight, caveat, or question.
Tonko et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: